Clinical trial tests new breast cancer drug as alternative to chemo
Clinical trial tests new breast cancer drug as alternative to chemo WAFB
Онкология
🎗️Лента новостей
🎗️
Онкология
Decipher prostate test predicts benefit from adding hormone therapy to radiation, phase III trial shows
Decipher prostate test predicts benefit from adding hormone therapy to radiation, phase III trial shows cancerletter.com
🎗️
Онкология
Cedars-Sinai, UA Cancer Center study shows how missing pieces of Y chromosome drive cancer in men
Cedars-Sinai, UA Cancer Center study shows how missing pieces of Y chromosome drive cancer in men cancerletter.com
Онкология
Учёные связали 2,3 млн случаев рака с обычными инфекциями
Учёные связали 2,3 млн случаев рака с обычными инфекциями life.ru
Онкология
NCI is Seeking a Deputy Director for the Division of Cancer Biology
NCI is Seeking a Deputy Director for the Division of Cancer Biology Oncodaily
Онкология
Nicole Michmerhuizen Shares Insights Into NUP98-Rearranged Leukemia at AACR Special Conference
Nicole Michmerhuizen Shares Insights Into NUP98-Rearranged Leukemia at AACR Special Conference Oncodaily
Онкология
Rani Khetarpal: A New Way to Navigate Cancer Care in the UK
Rani Khetarpal: A New Way to Navigate Cancer Care in the UK Oncodaily
Онкология
Jennifer Bires: When Community Becomes Part of Cancer Care
Jennifer Bires: When Community Becomes Part of Cancer Care Oncodaily
Онкология
A Journey of Discovery in Cancer Research – NFCR
A Journey of Discovery in Cancer Research – NFCR Oncodaily
Онкология
Простой способ предупредить рак - что выяснили ученые
Простой способ предупредить рак - что выяснили ученые Cursorinfo
Онкология
Простой способ предупредить рак - что выяснили ученые
Простой способ предупредить рак - что выяснили ученые Cursorinfo
Онкология
Heath Skinner: Celebrating the UPMC Radiation Oncology Team at ASTRO 2026
Heath Skinner: Celebrating the UPMC Radiation Oncology Team at ASTRO 2026 Oncodaily
Онкология
Early trial of ovarian cancer drug seeks patients for high-dose group
Early trial of ovarian cancer drug seeks patients for high-dose group Rare Cancer News